# Crucible Therapeutics Limited

## Details

- **Company number:** [14690230](https://find-and-update.company-information.service.gov.uk/company/14690230)
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 27 Feb 2023
- **Registered office:** THE INNOVATION CENTRE, 217 PORTOBELLO, SHEFFIELD, S1 4DP
- **Nature of business:** [72110](/sic/72110) Research and experimental development on biotechnology
- **Corporate group:** [GMV Nominees Ltd](/group/4) (48359 companies)



## Officers

| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FOLEY, Jonathan | director | 21 Sep 2023 |  |



## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Professor Guillaume Marcel Pierre Hautbergue | right-to-appoint-and-remove-directors | 27 Feb 2023 | 21 Sep 2023 |
| Argobio S.A.S. | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 14 Feb 2024 |  |
| Northern Gritstone Limited | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 14 Feb 2024 |  |



## Accounts

| Year ended | Cash | Employees |
|---|---|---|
| 28 Feb 2026 | £1,804,883 | 0 |



## Owned by

Crucible Therapeutics Limited → [Northern Gritstone Limited](/company/12982592)




## Directors' other companies

- [FOLEY, Jonathan](/person/6366100) - director at [CFA Discovery Ltd](/company/14296085)



## Companies at the same address

- [Aeni Limited](/company/17146875) (17146875)
- [Amplisi Limited](/company/16625534) (16625534)
- [Bettison.org Limited](/company/05604762) (05604762)
- [Blastech Limited](/company/04755214) (04755214)
- [Cybpass Limited](/company/16690289) (16690289)
- [Evolutor Limited](/company/13882589) (13882589)
- [Full Scale Dynamics Limited](/company/06680024) (06680024)
- [Houndkirk View Management Company Limited](/company/16080930) (16080930)
- [Instruct3d Limited](/company/15677349) (15677349)
- [Keapstone Therapeutics Limited](/company/10594127) (10594127)